This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Skip to main content
United Kingdom | EN-GB

Add a bookmark to get started

Cortex - Life Sciences Insights

| less than a minute read

German govt. introduces prescription healthcare apps and opens fast-track pathway to reimbursement

The new German Digital Healthcare Act (Digitale‑Versorgung‑Gesetz/DVG), among many other groundbreaking changes, enables any physician or psychotherapist in Germany to prescribe digital health applications (DH-Apps) to the more than 70 million members of the population who are covered by the country’s statutory healthcare system. 

Makers of DH-Apps are being given superfast access to the highly lucrative German healthcare reimbursement system. Most notably, for a period of up to 12 months they have the chance to additionally test their products and gather real-world scientific data on their benefits. The German statutory health insurance funds will also be required to fully reimburse the sales price of DH-Apps already during their testing & development, which their makers may freely set at the start.

This legislation massively pushes Germany towards Healthcare 4.0 and may usher in an era of great opportunities: not only for traditional players in the life sciences and healthcare market, but also for newcomers to this sector, including tech giants, tech startups and data-driven enterprises.


artificial intelligence, data protection, digital health apps, life sciences, medical devices, digital health, digital therapeutics, internet of things, reimbursement models